|Articles|February 1, 2011

Pharmaceutical Executive

  • Pharmaceutical Executive-02-01-2011
  • Volume 0
  • Issue 0

Pharmaceutical Executive Digital Edition - February 2011

The Promise Of Translational Medicine

Articles in this issue


Related to this article

Pharmaceutical Executive Daily
FDA reportedly shelves its Commissioner’s National Priority Voucher program, Eli Lilly breaks ground on a $3.5 billion Pennsylvania manufacturing site for next-generation obesity treatments, and Parexel’s Stacy Hurt on how small protocol decisions can become enrollment and retention barriers.